Drug profile · INN
daclatasvir hydrochloride
DAKLINZA
daclatasvir hydrochloride (DAKLINZA) is a nonstructural protein 5a inhibitor.
PMDA: approved
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — daclatasvir hydrochloride
- Class
- —
- Route
- —
- Patents
- 0
- Programs
- 0
- Data quality
- 0.78
Quick answer
daclatasvir hydrochloride (DAKLINZA) is a nonstructural protein 5a inhibitor.
Key facts
INN daclatasvir hydrochloride
Brand DAKLINZA
Mechanism Nonstructural protein 5A inhibitor
Target Nonstructural protein 5A
Mechanism of action
Nonstructural protein 5A inhibitor
Primary target: Nonstructural protein 5A
Approval history
| Authority | Status | Date |
|---|---|---|
| PMDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is daclatasvir hydrochloride?
daclatasvir hydrochloride (DAKLINZA) is a nonstructural protein 5a inhibitor.
What is the brand name for daclatasvir hydrochloride?
DAKLINZA is a marketed brand name for daclatasvir hydrochloride. Check FDA Drugs@FDA for the current US label holder and prescribing information.